# US 2012/0253337 A1 · Regulating internal pressure of a cryotherapy balloon catheter

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253337 A1
- Document ID: US20120253337A1
- Status: Published application
- Kind: A1
- Application number: 13/482,722
- Filed: 2012-05-29
- Published: 2012-10-04
- Earliest claimed: 2008-05-29
- Assignees: Boston Scientific Scimed, Inc.
- Inventors: JAMES R. WATSON
- Web page: https://patentgrep.com/patent/US20120253337A1

## CPC

- A61B 18/02: by cooling, e.g. cryogenic techniques
- A61M 25/1006: {Balloons formed between concentric tubes}
- A61M 25/1011: {Multiple balloon catheters}
- A61B 2018/0022: {Balloons}
- A61B 2018/00375: {Ostium, e.g. ostium of pulmonary vein or artery}
- A61B 2018/00577: {Ablation}
- A61B 2018/00642: {with feedback, i.e. closed loop control}
- A61B 2018/00666: {using a threshold value}
- A61B 2018/00744: {Fluid flow}
- A61B 2018/0212: {using an instrument inserted into a body lumen, e.g. catheter}
- A61B 2018/0262: {using a circulating cryogenic fluid}
- A61B 2018/0287: {the fluid flowing through a long thin tube with spiral shape}
- A61B 2090/064: {for measuring force, pressure or mechanical tension}
- A61M 25/10185: {Valves}
- A61M 2025/1013: {with concentrically mounted balloons, e.g. being independently inflatable}
- A61M 2025/1081: {having sheaths or the like for covering the balloon but not forming a permanent part of the balloon, e.g. retractable, dissolvable or tearable sheaths}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A method of performing a cryotherapy procedure can include introducing a cryotherapy balloon catheter at a treatment site inside a patient's body; regulating, during a first phase of a cryotherapy procedure, flow of cryogenic fluid to and exhaust from a distal balloon portion of the cryotherapy balloon catheter to cause an initial pressure to be maintained inside the distal balloon portion that is sufficiently high to cause an outer wall of the distal balloon portion to be pressed against body tissue at the treatment site; and regulating, during a second phase of the cryotherapy procedure, flow of cryogenic fluid to and exhaust from the distal balloon portion to cause a) a temperature inside the distal balloon portion to reach a value sufficient to deliver therapeutic levels of cryotherapy to the body tissue, and b) a second-phase pressure to be maintained that is within a threshold value of the initial pressure.

## Claims

### Claim 1

A method of performing a cryotherapy procedure, the method comprising:
introducing a cryotherapy balloon catheter at a treatment site inside a patient's body;
during a first phase of a cryotherapy procedure, using a pressure source to inflate a distal balloon portion of the cryotherapy balloon catheter, independently of a release of cryogenic fluid into the distal balloon portion, to expand the distal balloon portion and to cause an initial pressure to be maintained inside the distal balloon portion that is sufficiently high to cause an outer wall of the distal balloon portion to be pressed against body tissue at the treatment site;
starting a flow of cryogenic fluid to the distal balloon portion and a corresponding flow of exhaust from the distal balloon portion; and
regulating, during a second phase of the cryotherapy procedure, flow of cryogenic fluid to and exhaust from the distal balloon portion to cause a) a temperature inside the distal balloon portion to reach a value sufficient to deliver therapeutic levels of cryotherapy to the body tissue, and b) a second-phase pressure to be maintained that is within a threshold value of the initial pressure.

### Claim 2 (depends on 1)

The method of claim 1, wherein the threshold value is substantially 10% of the initial pressure.

### Claim 3 (depends on 1)

The method of claim 1, wherein the threshold value is substantially 5% of the initial pressure.

### Claim 4 (depends on 1)

The method of claim 1, wherein the initial pressure is in the range of 10-20 pounds per square inch absolute (PSIA).

### Claim 5 (depends on 1)

The method of claim 1, wherein the threshold value is substantially 0.5 pounds per square inch absolute (PSIA).

### Claim 6 (depends on 1)

The method of claim 1, wherein using the pressure source to inflate the distal balloon portion during the first phase comprises regulating flow of inflation fluid to the distal balloon portion of the cryotherapy balloon catheter such that a temperature on the outer wall is maintained that does not substantially cool the body tissue beyond its nominal temperature.

### Claim 7 (depends on 1)

The method of claim 1, wherein regulating during the second phase comprises regulating flow of cryogenic fluid to and exhaust from the distal balloon portion of the cryotherapy balloon catheter such that the temperature on the outer wall is sustained at −80° C.+/−10° C.

### Claim 8 (depends on 1)

The method of claim 1, wherein regulating during the second phase comprises regulating flow of cryogenic fluid to and exhaust from the distal balloon portion of the cryotherapy balloon catheter such that a quantity of heat can be removed that is sufficient to circumferentially ablate pulmonary vein tissue of an average human adult to a depth of 5 mm within five minutes.

### Claim 9 (depends on 1)

The method of claim 1, further comprising regulating, after the second phase, flow of cryogenic fluid to and exhaust from the distal balloon portion such that minimal heat is extracted from the body tissue, to allow the body tissue to warm up.

### Claim 10 (depends on 9)

The method of claim 9, further comprising at least partially deflating the distal balloon portion, introducing the cryotherapy balloon catheter to a second treatment site, and regulating the pressure source and the flow of cryogenic fluid to and exhaust from the distal balloon portion to repeat the first and second phases of the cryotherapy procedure at the second treatment site.

### Claim 11 (depends on 1)

The method of claim 1, wherein regulating flow of cryogenic fluid to and exhaust from the distal balloon portion comprises regulating flow of liquid nitrous oxide to the distal balloon portion and flow of gaseous nitrous oxide from the distal balloon portion.

### Claim 12

A cryotherapy catheter comprising:
an elongate member and an inflatable balloon at a distal end of the elongate member, the elongate member having lumens formed therein to supply inflation fluid and cryogenic fluid to a chamber of the balloon and to channel exhaust from the balloon chamber; and
a controller programmed to control a first rate at which the inflation fluid is supplied to the balloon chamber, a second rate at which cryogenic fluid is supplied to the balloon chamber, and a third rate at which exhaust is channeled from the balloon chamber, wherein the controller is programmed to a) inflate the balloon using a pressure source to deliver inflation fluid to develop, during a first phase of a cryotherapy procedure, a first pressure inside the balloon chamber, and b) deliver cryogenic fluid to the balloon chamber and exhaust from the balloon chamber to maintain, during a second phase of the cryotherapy procedure, a pressure inside the balloon chamber that is within a threshold value of the first pressure, at a temperature that is sufficiently low to extract heat, at a therapeutic rate, from an environment adjacent to the outer wall.

### Claim 13 (depends on 12)

The cryotherapy catheter of claim 12, wherein a diameter of the elongate member is sized such that inflatable balloon can be routed, in a deflated state, to the left atrium of an adult human patient.

### Claim 14 (depends on 13)

The cryotherapy catheter of claim 13, further comprising a guidewire and corresponding guidewire lumen.

### Claim 15 (depends on 12)

The cryotherapy catheter of claim 12, wherein the inflatable balloon comprises a compliant material configured to enable the balloon to inflate under a pressure of 0.5 pounds per square inch (PSI) or less above an ambient pressure that is adjacent to and outside the inflatable balloon.

### Claim 16 (depends on 12)

The cryotherapy catheter of claim 12, wherein the inflatable balloon comprises an outer balloon and inner balloon that is separate from the outer balloon, wherein the inner balloon defines the chamber.

### Claim 17 (depends on 12)

The cryotherapy catheter of claim 12, wherein the inflatable balloon is configured to deliver, when inflated, cryotherapy to an ostium or antrum of a human patient's pulmonary vein.

### Claim 18 (depends on 12)

The cryotherapy catheter of claim 12, wherein the inflatable balloon is configured to deliver cryotherapy to a human patient's prostate.

### Claim 19 (depends on 12)

The cryotherapy catheter of claim 12, wherein the controller is programmed to inflate the balloon independently of delivering cryogenic fluid to the balloon.
